Here’s an interesting piece in the NY Times on Stanford’s plans to develop a new continuing medical education program that is completely devoid of industry influence…except for the minor detail that it is underwritten entirely by Pfizer.
What do you think—“OK” if Pfizer really has no say in the content, or “not OK” because the conflict of interest is inherent in the Pfunding mechanism? (take our blog survey!)
Since this is an infection prevention blog, I’ll pose a parallel example specific to our field: what if Cepheid approached your infection prevention program and agreed to give you a million dollars to put together a year-long series of CME programs on MRSA control…..no strings attached, and you get to choose the speakers and content. Would you take it?
Monday, January 11, 2010
Subscribe to:
Post Comments (Atom)
OSHA! OSHA! OSHA!
In many parts of the country, as rates of COVID-19 are declining and vaccination coverage is increasing (albeit with substantial variati...
-
In many parts of the country, as rates of COVID-19 are declining and vaccination coverage is increasing (albeit with substantial variati... -
This is a guest post by Jorge Salinas, MD, Hospital Epidemiologist at the University of Iowa Hospitals & Clinics. There is virtually no...
-
I’m surprised that we can’t stop arguing about the modes of SARS-CoV-2 transmission, despite the fact that most experts (including our frie...
I find it fascinating that not only is there a huge conflict of interest here but how self-righteous Stanford seems to be about the whole issue.
ReplyDelete